Health Moderna Halts Development of CMV Vaccine Following Phase 3 Failure Moderna has announced that its cytomegalovirus (CMV) vaccine has failed a pivotal Phase 3 study. As a result, the company will cease most further... Editorial7 hours ago
Health Cytokinetics Unveils Promising Heart Drug Data at ESC25 Cytokinetics has announced that its cardiac myosin inhibitor, aficamten, may redefine the standard of care for patients with heart muscle disorders. This revelation came... Editorial30 August, 2025
Business HMNC Brain Health Advances Phase 3 Trials for Depression Drug HMNC Brain Health has announced plans to move forward with Phase 3 clinical trials for its depression drug, despite the product’s failure to meet... Editorial5 August, 2025